By suppressing tumor growth and metastasis through the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway, NCOA7 emerges as a promising prognostic marker and potential therapeutic target for ccRCC [14]. The gene discussed is NCOA7; the disease is neoplasm.